Inflammation and atherosclerosis in acute coronary syndromes.
We review the role of inflammation in coronary artery disease, particularly its conversion from a chronic to an acute illness. An overview is provided of the various biochemical reactions that are grouped under the heading of inflammation and which lead to the development and progression of atherosclerotic vascular disease and its clinical consequences, especially acute coronary syndromes. The potential role of inflammatory markers in identifying patients at risk and for primary and secondary prevention of events is explored. The impact of current pharmacologic therapies on inflammation and possible future medicines are also discussed.
Murtagh
Blaithnead M
BM
Cardiology Division, University of Texas, 6431 Fannin, Suite 1246, Houston, TX 77030, USA.
Anderson
H Vernon
HV
D000208:Acute Disease; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000473:pathology*; D018450:Disease Progression; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000503:physiopathology*; D013577:Syndrome
D000893:Anti-Inflammatory Agents